Filing Details
- Accession Number:
- 0001225208-15-004549
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2015-02-18 17:48:47
- Reporting Period:
- 2015-02-13
- Filing Date:
- 2015-02-18
- Accepted Time:
- 2015-02-18 17:48:47
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
9892 | Bard C R Inc | BCR | Surgical & Medical Instruments & Apparatus (3841) | 221454160 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1463423 | C Jim Beasley | C/O C. R. Bard, Inc. 730 Central Avenue Murray Hill NJ 07974 | Group President | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Disposition | 2015-02-13 | 806 | $174.59 | 39,050 | No | 4 | F | Direct | |
Common Stock | Disposition | 2015-02-17 | 1,949 | $174.92 | 37,101 | No | 4 | F | Direct | |
Common Stock | Disposition | 2015-02-17 | 9,904 | $174.58 | 27,197 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | F | Direct | |
No | 4 | F | Direct | |
No | 4 | S | Direct |
Reported Non-Derivative Holdings
Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
---|---|---|---|
Common Stock | 3,093 | Indirect | 401(k) Plan |
Footnotes
- Shares withheld to pay taxes upon vesting of restricted stock granted under the Company's 2003 Long Term Incentive Plan.
- Shares withheld to pay taxes upon vesting of restricted stock units acquired through deferral of compensation under the Company's Management Stock Purchase Program.
- Sales are pursuant to a previously disclosed 10b5-1 plan.
- Represents the weighted average sales price for price increments ranging from $174.25 to $174.95. The Reporting Person undertakes to provide, upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each separate price for all transactions reported on this Form 4.